Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2020

Open Access 01-02-2020 | Acromegaly | Endocrine imaging

Pachydermoperiostosis mimicking the acral abnormalities of acromegaly

Authors: Pedro Marques, Maria Stelmachowska-Banas, David Collier, Florian Wernig, Márta Korbonits

Published in: Endocrine | Issue 2/2020

Login to get access

Excerpt

Bones and soft tissues of hands and feet can be affected by different conditions, including genetic, metabolic or systemic disorders [1]. Acromegaly is a condition caused by excessive secretion of growth hormone (GH) leading to elevated insulin growth factor-1 (IGF-1) levels, which is characterised by somatic overgrowth and physical disfigurement notably affecting hands and feet [2]. However, there are other conditions that can mimick the clinical features seen in acromegaly without GH/IGF-1 anomalies, termed as pseudoacromegaly [1]. …
Literature
1.
2.
3.
Metadata
Title
Pachydermoperiostosis mimicking the acral abnormalities of acromegaly
Authors
Pedro Marques
Maria Stelmachowska-Banas
David Collier
Florian Wernig
Márta Korbonits
Publication date
01-02-2020
Publisher
Springer US
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02168-5

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue

Original Article

Sex-related differences in self-care behaviors of adults with type 2 diabetes mellitus

Research Letter

Low-dose glucocorticoid can lead to hypokalemic paralysis

Original Article

Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans

Viewpoint

Growth hormone releasing hormone in the unfolded protein response context

Original Article

Associations of apnea hypopnea index and educational attainments with microvascular complications in patients with T2DM

Original Article

Sonographic features of follicular variant of papillary thyroid carcinoma (FV-PTC) and diagnostic performance of the 2017 ACR TI-RADS in FV-PTC
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits